4:15 pm Dicerna Pharmaceuticals initiates Phase 1 study of DCR-MYC in patients with solid tumors and hematological malignancies
View todays social media effects on DRNA
View the latest stocks trending across Twitter. Click to view dashboard
See who Dicerna is hiring next, click here to view
